|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1
|
|
pubmed:dateCreated |
2011-6-6
|
|
pubmed:abstractText |
More than 1 million prostate biopsies are conducted yearly in the United States. The low specificity of prostate-specific antigen (PSA) results in diagnostic biopsies in men without prostate cancer (PCa). Additional information, such as genetic markers, could be used to avoid unnecessary biopsies.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1873-7560
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2011 European Association of Urology. Published by Elsevier B.V. All rights reserved.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
60
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
21-8
|
|
pubmed:meshHeading |
pubmed-meshheading:21295399-Aged,
pubmed-meshheading:21295399-Cohort Studies,
pubmed-meshheading:21295399-Humans,
pubmed-meshheading:21295399-Male,
pubmed-meshheading:21295399-Middle Aged,
pubmed-meshheading:21295399-Multifactorial Inheritance,
pubmed-meshheading:21295399-Polymorphism, Single Nucleotide,
pubmed-meshheading:21295399-Prognosis,
pubmed-meshheading:21295399-Prostatic Neoplasms,
pubmed-meshheading:21295399-Risk Assessment,
pubmed-meshheading:21295399-Sweden
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
Polygenic risk score improves prostate cancer risk prediction: results from the Stockholm-1 cohort study.
|
|
pubmed:affiliation |
Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
